本文選題：藥品集中招標 + 基層醫(yī)療衛(wèi)生機構(gòu)��； 參考：《山西醫(yī)科大學》2017年碩士論文

【摘要】：目的:通過對比山西省2015年基本藥物集中招標藥品中標前后基層醫(yī)療衛(wèi)生機構(gòu)在采購結(jié)算平臺中的藥品配送供應數(shù)據(jù),反映山西省藥品集中招標采購的現(xiàn)狀,分析基層醫(yī)療衛(wèi)生機構(gòu)藥品供應配送的影響因素,尋找提高基層醫(yī)療衛(wèi)生機構(gòu)基本藥物配送率的有效方法,為完善藥品集中采購提供理論依據(jù)。方法:運用文獻研究法、描述性研究方法,對山西省基層醫(yī)療衛(wèi)生機構(gòu)2015年基本藥物采購數(shù)據(jù)、2016年基本藥物采購數(shù)據(jù)、山西省2015年基本藥物集中招標采購藥品雙信封指標等數(shù)據(jù)進行了統(tǒng)計與分析,采用藥品配送率作為考察藥品供應的指標,揭示了藥品集中招標政策對于藥品配送率的影響。結(jié)果:由于山西省2015年基本藥物集中招標采購采用了改進后的雙信封招標機制,2015年基本藥物集中招標中標產(chǎn)品數(shù)量增加,基層醫(yī)療衛(wèi)生機構(gòu)基本藥物用藥選擇范圍大大增加。所有中標產(chǎn)品全部為經(jīng)濟技術(shù)標合格產(chǎn)品中的最低價;中標產(chǎn)品的經(jīng)濟技術(shù)標平均得分為83.89,高于所有投標產(chǎn)品的平均分81.12;通過改進后的雙信封入圍規(guī)則跟標入圍產(chǎn)品的經(jīng)濟技術(shù)標平均得分為85.22分,高于最低價直接入圍產(chǎn)品的平均分82.48。2016年山西省基層醫(yī)療衛(wèi)生機構(gòu)基本藥物整體的配送率達到了94.94%,相比2015年的83.50%有較大幅度提高,能夠較好的滿足基層醫(yī)療衛(wèi)生機構(gòu)的臨床用藥需求。2016年基層醫(yī)療衛(wèi)生機構(gòu)短缺藥品品種只有19個,相比2015年175個品種短缺大幅減少,絕大部分藥品短缺的問題得到了解決�；鶎俞t(yī)療衛(wèi)生機構(gòu)2016年基本藥物網(wǎng)上采購藥品配送率與藥品的報價(r=0.413,P0.001)、報價水平(r=0.255,P0.001)、采購總量(r=0.343,P0.001)、采購總金額(r=0.600,P0.001)存在正相關的關系。結(jié)論:山西省2015年基本藥物集中招標采購方案設計科學合理,有效的選擇了價格最低且質(zhì)量較高的產(chǎn)品作為中標產(chǎn)品,并在很大程度上解決了藥品短缺問題。藥品利潤是決定配送率的最主要因素,應當引導或干預企業(yè)在獲取合理利益的同時必須提高價格低、采購金額小產(chǎn)品的配送率,推動藥品供應市場良性發(fā)展。對于報價過低的產(chǎn)品應當重點關注配送情況,避免出現(xiàn)短缺問題影響基層醫(yī)療機構(gòu)臨床用藥。
[Abstract]:Objective: to compare the drug distribution and supply data of primary medical and health institutions in the purchasing and settlement platform before and after the central bidding of essential drugs in Shanxi Province in 2015, so as to reflect the current situation of drug centralized bidding procurement in Shanxi Province. This paper analyzes the influencing factors of drug supply and distribution in primary medical and health institutions, and looks for an effective method to improve the distribution rate of essential drugs in primary medical and health institutions, thus providing a theoretical basis for improving the centralized procurement of drugs. Methods: using the method of literature research and descriptive research, we analyzed the data of essential drugs procurement in primary medical and health institutions in Shanxi Province in 2015 and 2016, respectively. Based on the statistics and analysis of the index of double envelopes of essential drugs in Shanxi Province in 2015, this paper uses the drug distribution rate as the index to investigate the drug supply, and reveals the influence of the centralized bidding policy on the drug distribution rate. Results: because Shanxi province adopted the improved double envelopes bidding mechanism in 2015, the number of products won in 2015 increased, and the selection range of essential drugs in primary medical and health institutions increased greatly. All the winning products are the lowest price in the qualified products. The average economic and technical score of the winning products is 83.89, which is higher than the average score of 81.12 for all bidding products, and 85.22 for the products with the improved double-envelope entry rules. The average distribution rate of essential drugs in primary medical and health institutions in Shanxi Province reached 94.94% in 2016, compared with 83.50% in 2015, compared with 83.50% in 2015. In 2016, there were only 19 kinds of medicines in shortage in primary medical and health institutions, compared with 175 in 2015, the shortage of medicines was greatly reduced, and most of the problems of drug shortage were solved. There was a positive correlation between the drug delivery rate of primary medical and health institutions in 2016 and the quotation level of 0.255g / P0.001N, total purchase amount of 0.343n / P0.001and total purchase amount of 0.600 / P0.001 / r / r ~ (0.600) / P ~ (0.001) / P ~ (0.001) / r ~ (?) / r ~ (0.25) / P ~ (0.001) / P ~ (0.001). Conclusion: the project of central bidding and purchasing of essential drugs in Shanxi Province in 2015 is scientific and reasonable, and the products with the lowest price and higher quality are selected as the winning products effectively, and the shortage of drugs is solved to a great extent. The profit of drugs is the most important factor to determine the distribution rate. It is necessary to guide or intervene the enterprises to increase the distribution rate of small products in order to promote the healthy development of the drug supply market while obtaining reasonable benefits. In order to avoid the shortage of drugs in primary medical institutions, we should focus on the distribution of products with too low price.
【學位授予單位】：山西醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R95

【參考文獻】

相關期刊論文 前10條

1 武麗娜;方宇;楊才君;沈倩;常捷;朱穩(wěn)穩(wěn);葉丹;呂冰;楊世民;;我國藥品短缺問題研究進展評述[J];中國藥事;2016年05期

2 伍世恒;吳秋云;;藥品短缺現(xiàn)象頻發(fā)倒逼醫(yī)藥價格改革[J];中國藥業(yè);2016年10期

3 孫飛;付東普;;中國藥品流通績效評價研究——基于384家藥品流通批發(fā)企業(yè)的樣板數(shù)據(jù)[J];經(jīng)濟與管理;2016年02期

4 吳東美;;別嘌醇片壟斷協(xié)議案對加強藥品領域競爭監(jiān)管的啟示[J];中國價格監(jiān)管與反壟斷;2016年02期

5 羅莉;陳曉雋;陳勇;;某地藥品安全監(jiān)管信息化建設現(xiàn)狀分析及創(chuàng)新策略[J];中國藥業(yè);2016年02期

6 郭志剛;洪冬U，

本文編號：1815149